Topas Therapeutics
A biotechnology company focused on developing products to address areas of major unmet need.
Total raised
€40M
€40,000,000
Funding rounds
2
Investors
8
distinct backers
Active since
2020-10
latest 2021-07
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood15
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▲ 20y since founding
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-29 | Series B | €18M | BioMedPartners,Boehringer Ingelheim Venture Fund,EMBL Ventures,Epidarex Capital,Evotec,Gimv+1 more | View deal → |
| 2020-10-19 | Series B | €22M | BioMedPartners,Vesalius Biocapital Partners | View deal → |
Investors
8Related news
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software